expressionedits is a startup based in Germany, most recent round Seed, 1 tracked investor.
Based in Germany, expressionedits is a startup founded in 2024. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
expressionedits is developing a novel gene editing platform utilizing CRISPR-Cas technology to precisely correct disease-causing mutations. This aims to offer higher precision, efficiency, and safety for treating genetic diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.